Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Relation of Carotid Artery 18F-FDG Uptake to C-Reactive Protein and Framingham Risk Score in a Large Cohort of Asymptomatic Adults

Tae Soo Noh, Seung-Hwan Moon, Young Seok Cho, Sun Pyo Hong, Eun Jeong Lee, Joon Young Choi, Byung-Tae Kim and Kyung-Han Lee
Journal of Nuclear Medicine December 2013, 54 (12) 2070-2076; DOI: https://doi.org/10.2967/jnumed.113.119602
Tae Soo Noh
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seung-Hwan Moon
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Young Seok Cho
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sun Pyo Hong
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eun Jeong Lee
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joon Young Choi
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byung-Tae Kim
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyung-Han Lee
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Relation of FRS to M-TBR, IMT, and hsCRP. (A) M-TBR (left), IMT (middle), and hsCRP levels (right) according to FRS categories. (B) FRS according to high and low M-TBR (left) and IMT groups (right), adjusting for age by stratification. P < 0.001 for age effects on M-TBR and IMT. Bars are mean ± SE. n.s. = not significant.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Relation of hsCRP to FRS, M-TBR, and IMT. (A) FRS (left), M-TBR (middle), and IMT levels (right) according to hsCRP categories. (B) Estimated risk based on FRS in subjects categorized by hsCRP and substratified by M-TBR (left) or IMT level (right). Bars are mean ± SE. n.s. = not significant.

Tables

  • Figures
    • View popup
    TABLE 1

    Clinical Characteristics of Study Subjects Stratified by M-TBR and IMT

    M-TBRIMT
    VariableTotal (n = 1,181)<1.7 (n = 886)≥1.7 (n = 295)<0.75 mm (n = 888)≥0.75 mm (n = 293)
    Age (y)52.0 ± 6.551.4 ± 5.853.9 ± 7.9*50.9 ± 5.655.4 ± 7.7*
    Sex
     Male1,114843271†836278
     Female674324†5215
    Body mass index (kg/m2)24.5 ± 2.424.4 ± 2.524.8 ± 2.1†24.3 ± 2.4225.0 ± 2.24*
    Systolic blood pressure (mm Hg)118.9 ± 15.7118.3 ± 15.4120.8 ± 16.6†118.0 ± 15.3121.6 ± 16.8*
    Diastolic blood pressure (mm Hg)76.7 ± 10.476.8 ± 10.676.7 ± 9.676.7 ± 10.577.0 ± 10.0
    Waist circumference (cm)85.8 ± 6.985.5 ± 7.087.0 ± 6.2†85.2 ± 6.887.8 ± 6.7*
    Abdominal fat (%)0.9 ± 0.00.9 ± 0.00.9 ± 0.0*0.91 ± 0.00.9 ± 0.0*
    Fasting blood glucose97.5 ± 18.497.7 ± 19.796.7 ± 13.996.5 ± 18.1100.3 ± 19.0‡
    HbA1c (%)5.7 ± 0.65.7 ± 0.75.7 ± 0.55.66 ± 0.635.81 ± 0.63*
    Total cholesterol (mmol/dL)196.2 ± 33.1194.8 ± 33.2200.6 ± 32.2§195.7 ± 31.9197.8 ± 36.2
    HDL cholesterol (mmol/dL)50.3 ± 12.450.7 ± 12.449.1 ± 12.350.9 ± 12.448.4 ± 12.3‡
    LDL cholesterol (mmol/dL)122.0 ± 28.6120.5 ± 28.4126.4 ± 28.7‡121.1 ± 27.9124.6 ± 30.5
    Triglyceride (mmol/dL)141.9 ± 73.7140.0 ± 76.1147.6 ± 65.6141.6 ± 76.3142.3 ± 65.1
    FRS (%)12.3 ± 8.711.5 ± 7.814.8 ± 10.5*10.9 ± 7.2316.4 ± 11.0*
     Median (Q1–Q3)9.9 (6.6–14.9)9.1 (6.2–14.1)11.8 (7.9–18.0)9.0 (6.1–13.5)13.2 (8.6–20.7)
    FRS ≥ 10%
     Odds ratio1.01.9*1.02.6*
     95% CI1.4–2.5*1.9–3.4*
    IMT0.65 ± 0.150.64 ± 0.130.70 ± 0.20*0.59 ± 0.080.84 ± 0.14*
    M-TBR1.60 ± 0.151.53 ± 0.111.80 ± 0.09*1.59 ± 0.151.64 ± 0.16*
    Mean TBR1.38 ± 0.131.32 ± 0.091.53 ± 0.07*1.37 ± 0.121.40 ± 0.13*
    Maximum SUV1.61 ± 0.141.56 ± 0.111.77 ± 0.12*1.60 ± 0.141.65 ± 0.15*
    Mean SUV1.39 ± 0.111.35 ± 0.091.50 ± 0.09*1.38 ± 0.111.41 ± 0.12*
    hsCRP (mg/dL)0.12 ± 0.240.11 ± 0.240.13 ± 0.230.11 ± 0.210.13 ± 0.31
    • ↵* P < 0.001.

    • ↵† P < 0.05.

    • ↵‡ P < 0.005.

    • ↵§ P < 0.01.

    • Data are mean ± SD. P values were calculated using t tests or Mann–Whitney tests.

    • View popup
    TABLE 2

    Multiple Regression Analysis for Independent Determinants for M-TBR and IMT According to Age Group

    VariableBSEP
    M-TBR, age < 50
     Abdominal fat1.10400.2204<0.0001
     FRS0.00250.00120.0340
     LDL cholesterol0.00060.00020.0188
    M-TBR, age ≥ 50
     Age0.00400.00100.0001
     Abdominal fat0.97400.1916<0.0001
     LDL cholesterol0.00080.00020.0001
     IMT0.10970.03960.0057
    IMT, age < 50
     Abdominal fat0.71850.20480.0005
     HbA1c0.02970.01050.0050
     Total cholesterol0.00040.00020.0339
     M-TBR0.09140.04440.0401
    IMT, age ≥ 50
     Age0.00760.00120.0331
     Abdominal fat−0.76860.3600<0.0001
     Body mass index0.01610.00450.0004
     FRS0.00250.00060.0001
     Mean TBR0.12980.04110.0017
    • B = β coefficient.

    • View popup
    TABLE 3

    Subject Characteristics Stratified by hsCRP and M-TBR

    hsCRP < 2 mg/dLhsCRP ≥ 2 mg/dL
    CharacteristicM-TBR < 1.7 (n = 797)M-TBR ≥ 1.7 (n = 254)PM-TBR < 1.7 (n = 89)M-TBR ≥ 1.7 (n = 41)P
    Age (y)51.4 ± 5.753.5 ± 7.7<0.000151.3 ± 6.956.5 ± 8.50.0003
    Body mass index (kg/m2)24.3 ± 2.424.7 ± 2.00.014324.9 ± 3.225.1 ± 2.80.7310
    Systolic blood pressure (mm Hg)118.2 ± 15.5120.8 ± 16.70.0218119.5 ± 15.0120.7 ± 15.90.6675
    Diastolic blood pressure (mm Hg)76.8 ± 10.576.7 ± 9.70.911876.5 ± 11.576.9 ± 9.30.8750
    Waist circumference (cm)85.2 ± 6.886.8 ± 6.00.000687.8 ± 8.187.8 ± 7.60.9716
    Abdominal fat (%)0.9 ± 0.00.9 ± 0.0<0.00010.9 ± 0.00.9 ± 0.00.0184
    Fasting blood glucose97.4 ± 19.396.9 ± 14.20.6610100.1 ± 23.196.1 ± 11.40.2974
    HbA1c (%)5.7 ± 0.65.7 ± 0.50.43375.8 ± 0.85.9 ± 0.60.4254
    Total cholesterol (mmol/dL)195.4 ± 32.5201.2 ± 31.80.0128189.4 ± 39.0196.7 ± 34.20.3096
    HDL cholesterol (mmol/dL)51.1 ± 12.550.1 ± 12.20.272146.8 ± 10.442.6 ± 11.30.0380
    LDL cholesterol (mmol/dL)120.8 ± 28.0126.4 ± 28.4<0.0001117.9 ± 31.6126.4 ± 30.70.1545
    Triglyceride (mmol/dL)140.2 ± 76.8145.7 ± 67.10.3054138.4 ± 70.0159.2 ± 53.90.0976
    IMT (mm)0.64 ± 0.130.68 ± 0.170.00010.65 ± 0.120.79 ± 0.23<0.0001
    M-TBR1.54 ± 0.111.79 ± 0.09<0.00011.51 ± 0.111.84 ± 0.10<0.0001
    Mean TBR1.33 ± 0.091.52 ± 0.07<0.00011.31 ± 0.101.55 ± 0.07<0.0001
    hsCRP (mg/dL)0.6 ± 0.40.7 ± 0.40.06805.8 ± 5.94.8 ± 4.60.3578
    • Data are mean ± SD. P values were calculated using t tests or Mann–Whitney tests.

    • View popup
    TABLE 4

    Subject Characteristics Stratified by hsCRP and IMT

    hsCRP < 2 mg/LhsCRP ≥ 2 mg/L
    CharacteristicIMT < 0.75 mm (n = 803)IMT ≥ 0.75 mm (n = 248)PIMT < 0.75 mm (n = 85)IMT ≥ 0.75 mm (n = 45)P
    Age (y)50.8 ± 5.455.5 ± 7.6<0.000151.8 ± 7.255.3 ± 8.40.0163
    Body mass index (kg/m2)24.3 ± 2.325.0 ± 2.20.000624.7 ± 3.325.5 ± 2.50.1571
    Systolic blood pressure (mm Hg)118.0 ± 15.3121.5 ± 16.90.0087118.8 ± 11.6122.0 ± 16.10.2516
    Diastolic blood pressure (mm Hg)76.7 ± 10.377.1 ± 10.10.603576.7 ± 11.676.4 ± 9.30.8879
    Waist circumference (cm)85.0 ± 6.5687.4 ± 6.70.000186.7 ± 8.689.9 ± 6.20.0290
    Abdominal fat (%)0.9 ± 0.00.9 ± 0.00.06250.92 ± 0.00.9 ± 0.00.0028
    Fasting blood glucose96.2 ± 17.4100.9 ± 19.90.000299.9 ± 23.396.7 ± 12.00.3917
    HbA1c (%)5.6 ± 0.65.8 ± 0.60.00155.8 ± 0.85.8 ± 0.60.8527
    Total cholesterol (mmol/dL)196.4 ± 31.7198.2 ± 34.30.5647189.7 ± 33.1195.6 ± 44.90.4024
    HDL cholesterol (mmol/dL)51.3 ± 12.549.3 ± 12.20.041246.6 ± 10.243.3 ± 11.70.0993
    LDL cholesterol (mmol/dL)121.3 ± 27.5124.8 ± 29.20.1471118.9 ± 28.3123.8 ± 36.70.4006
    Triglyceride (mmol/dL)141.6 ± 76.9141.4 ± 66.60.8980142.2 ± 71.1150.2 ± 54.90.5167
    IMT (mm)0.59 ± 0.080.84 ± 0.13<0.00010.60 ± 0.080.87 ± 0.18<0.0001
    M-TBR1.59 ± 0.151.62 ± 0.150.00481.56 ± 0.171.71 ± 0.17<0.0001
    Mean TBR1.37 ± 0.121.39 ± 0.130.00861.34 ± 0.141.46 ± 0.12<0.0001
    hsCRP (mg/dL)0.6 ± 0.40.7 ± 0.40.07085.3 ± 5.05.8 ± 6.20.6949
    • Data are mean ± SD. P values were calculated using t tests or Mann–Whitney tests.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 54 (12)
Journal of Nuclear Medicine
Vol. 54, Issue 12
December 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Relation of Carotid Artery 18F-FDG Uptake to C-Reactive Protein and Framingham Risk Score in a Large Cohort of Asymptomatic Adults
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Relation of Carotid Artery 18F-FDG Uptake to C-Reactive Protein and Framingham Risk Score in a Large Cohort of Asymptomatic Adults
Tae Soo Noh, Seung-Hwan Moon, Young Seok Cho, Sun Pyo Hong, Eun Jeong Lee, Joon Young Choi, Byung-Tae Kim, Kyung-Han Lee
Journal of Nuclear Medicine Dec 2013, 54 (12) 2070-2076; DOI: 10.2967/jnumed.113.119602

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Relation of Carotid Artery 18F-FDG Uptake to C-Reactive Protein and Framingham Risk Score in a Large Cohort of Asymptomatic Adults
Tae Soo Noh, Seung-Hwan Moon, Young Seok Cho, Sun Pyo Hong, Eun Jeong Lee, Joon Young Choi, Byung-Tae Kim, Kyung-Han Lee
Journal of Nuclear Medicine Dec 2013, 54 (12) 2070-2076; DOI: 10.2967/jnumed.113.119602
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • 18F-FDG Imaging of Carotid Arteries for Identifying the Vulnerable Patient: Are We at the Beginning of the End?
  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction?
  • Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism
  • PET/CT Imaging of Unstable Carotid Plaque with 68Ga-Labeled Somatostatin Receptor Ligand
  • The Future of Cardiovascular Imaging
  • Carotid FDG Uptake Improves Prediction of Future Cardiovascular Events in Asymptomatic Individuals
  • Oxidized Low-Density Lipoprotein Stimulates Macrophage 18F-FDG Uptake via Hypoxia-Inducible Factor-1{alpha} Activation Through Nox2-Dependent Reactive Oxygen Species Generation
  • 18F-FDG Imaging of Carotid Arteries for Identifying the Vulnerable Patient: Are We at the Beginning of the End?
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

Keywords

  • 18F-FDG
  • atherosclerosis
  • hsCRP
  • Framingham risk score
  • carotid artery
SNMMI

© 2025 SNMMI

Powered by HighWire